Abstract
By virtual screening, we identify the potential of asymmetric imidazole-4,5-dicarboxamide derivatives as E. coli-AcrB efflux pump inhibitors. The compounds are synthesized and their inhibitory activity is evaluated by a biological assay.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
